NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · Real-Time Price · USD
0.1728
-0.0322 (-15.71%)
At close: Nov 17, 2026, 4:00 PM EST
0.1738
+0.0010 (0.58%)
After-hours: Nov 17, 2026, 7:57 PM EST

NewGenIvf Group Statistics

Total Valuation

NewGenIvf Group has a market cap or net worth of $1.71 million. The enterprise value is -$1.07 million.

Market Cap1.71M
Enterprise Value -1.07M

Important Dates

The next estimated earnings date is Friday, November 20, 2026.

Earnings Date Nov 20, 2026
Ex-Dividend Date n/a

Share Statistics

NewGenIvf Group has 9.89 million shares outstanding.

Current Share Class 9.82M
Shares Outstanding 9.89M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.48%
Owned by Institutions (%) 0.03%
Float 9.78M

Valuation Ratios

The trailing PE ratio is 1.52 and the forward PE ratio is 0.00.

PE Ratio 1.52
Forward PE 0.00
PS Ratio 0.37
Forward PS n/a
PB Ratio 0.06
P/TBV Ratio 0.34
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.06.

Current Ratio 1.06
Quick Ratio 0.55
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -10.69

Financial Efficiency

Return on equity (ROE) is 5.51% and return on invested capital (ROIC) is -48.11%.

Return on Equity (ROE) 5.51%
Return on Assets (ROA) -26.91%
Return on Invested Capital (ROIC) -48.11%
Return on Capital Employed (ROCE) -42.55%
Weighted Average Cost of Capital (WACC) 26.97%
Revenue Per Employee $53,238
Profits Per Employee $12,864
Employee Count87
Asset Turnover 0.18
Inventory Turnover 15.76

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -100.00% in the last 52 weeks. The beta is 0.17, so NewGenIvf Group's price volatility has been lower than the market average.

Beta (5Y) 0.17
52-Week Price Change -100.00%
50-Day Moving Average 8.12
200-Day Moving Average 294.12
Relative Strength Index (RSI) 20.73
Average Volume (20 Days) 1,481,247

Short Selling Information

The latest short interest is 125,342, so 1.27% of the outstanding shares have been sold short.

Short Interest 125,342
Short Previous Month 2.47M
Short % of Shares Out 1.27%
Short % of Float 1.28%
Short Ratio (days to cover) 0.03

Income Statement

In the last 12 months, NewGenIvf Group had revenue of $4.63 million and earned $1.12 million in profits.

Revenue4.63M
Gross Profit 1.11M
Operating Income -11.03M
Pretax Income 951,299
Net Income 1.12M
EBITDA -10.69M
EBIT -11.03M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

The company has $4.43 million in cash and $1.65 million in debt, with a net cash position of $2.78 million or $0.28 per share.

Cash & Cash Equivalents 4.43M
Total Debt 1.65M
Net Cash 2.78M
Net Cash Per Share $0.28
Equity (Book Value) 25.71M
Book Value Per Share 733.75
Working Capital 618,325
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$14.64 million and capital expenditures -$181,842, giving a free cash flow of -$14.82 million.

Operating Cash Flow -14.64M
Capital Expenditures -181,842
Depreciation & Amortization 343,169
Net Borrowing 7.53M
Free Cash Flow -14.82M
FCF Per Share -$1.50
Full Cash Flow Statement

Margins

Gross margin is 23.89%, with operating and profit margins of -238.22% and 24.16%.

Gross Margin 23.89%
Operating Margin -238.22%
Pretax Margin 20.54%
Profit Margin 24.16%
EBITDA Margin -230.81%
EBIT Margin -238.22%
FCF Margin n/a

Dividends & Yields

NewGenIvf Group does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 65.76%
FCF Yield -870.85%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) 285.42%
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on October 23, 2026. It was a reverse split with a ratio of 1:8.

Last Split Date Oct 23, 2026
Split Type Reverse
Split Ratio 1:8

Scores

NewGenIvf Group has an Altman Z-Score of -0.71 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.71
Piotroski F-Score 1